These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6135376)

  • 1. The effect of withdrawal of beta-adrenergic blockade on intermittent claudication.
    Lepäntalo M; von Knorring J; Lindfors O; Scheinin TM
    Angiology; 1983 Jun; 34(6):401-11. PubMed ID: 6135376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta blockade and intermittent claudication.
    Lepäntalo M
    Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic blockade and peripheral vascular disease.
    Ingram DM; House AK; Thompson GH; Stacey MC; Castleden WM; Lovegrove FT
    Med J Aust; 1982 Jun; 1(12):509-11. PubMed ID: 6124873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials.
    Radack K; Deck C
    Arch Intern Med; 1991 Sep; 151(9):1769-76. PubMed ID: 1679624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does beta-blockade provoke intermittent claudication?
    Lepäntalo M; Aromaa A; Klaukka T; Lukkari E
    Acta Med Scand; 1985; 218(1):35-9. PubMed ID: 2864796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intermittent claudication and beta-blockaders. An unfortunate combination?].
    Andreassen AK; Gullestad L; Bjørnerheim R; Forfang K; Kjekshus J
    Tidsskr Nor Laegeforen; 1995 Feb; 115(6):725-8. PubMed ID: 7900137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is adrenergic betareceptor blockade contraindicated in patients with intermittent claudication?
    Svendsen TL; Jelnes R; Tønnesen KH
    Acta Med Scand Suppl; 1985; 693():129-32. PubMed ID: 2859742
    [No Abstract]   [Full Text] [Related]  

  • 8. Walking ability and ankle systolic pressures: observations in patients with intermittent claudication in a short-term walking exercise program.
    Carter SA; Hamel ER; Paterson JM; Snow CJ; Mymin D
    J Vasc Surg; 1989 Dec; 10(6):642-9. PubMed ID: 2585653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent claudication complicating beta-blockade.
    Rodger JC; Sheldon CD; Lerski RA; Livingstone WR
    Br Med J; 1976 May; 1(6018):1125. PubMed ID: 5171
    [No Abstract]   [Full Text] [Related]  

  • 10. The beta-adrenergic blockade withdrawal phenomenon.
    Walden RJ; Tomlinson B; Bhattacharjee P; Prichard BN
    J Pharmacol; 1983; 14 Suppl 2():35-48. PubMed ID: 6138470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beta-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease.
    Hiatt WR; Stoll S; Nies AS
    Circulation; 1985 Dec; 72(6):1226-31. PubMed ID: 2866047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of acebutolol and metoprolol on walking distances and distal blood pressure in hypertensive patients with intermittent claudication.
    Svendsen TL; Jelnes R; Tønnesen KH
    Acta Med Scand; 1986; 219(2):161-5. PubMed ID: 3515864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of walking and strength training on resting and exercise cardiovascular responses in patients with intermittent claudication.
    Grizzo Cucato G; de Moraes Forjaz CL; Kanegusuku H; da Rocha Chehuen M; Riani Costa LA; Wolosker N; Kalil Filho R; de Fátima Nunes Marucci M; Mendes Ritti-Dias R
    Vasa; 2011 Sep; 40(5):390-7. PubMed ID: 21948782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-controlled trial of ketanserin in the treatment of intermittent claudication.
    Cameron HA; Waller PC; Ramsay LE
    Angiology; 1987 Jul; 38(7):549-55. PubMed ID: 3304029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous electrocardiography recording at examination of walking capacity in patients with intermittent claudication.
    Kövamees A; Brundin T
    J Cardiovasc Surg (Torino); 1976; 17(6):509-12. PubMed ID: 993252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic blocking agents and intermittent claudication: systematic review.
    Miyajima R; Sano K; Yoshida H
    Yakugaku Zasshi; 2004 Nov; 124(11):825-31. PubMed ID: 15516809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
    Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
    Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
    Delis KT; Nicolaides AN; Wolfe JH; Stansby G
    J Vasc Surg; 2000 Apr; 31(4):650-61. PubMed ID: 10753272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized placebo-controlled, double-blind trial of ketanserin in treatment of intermittent claudication.
    Walden R; Bass A; Rabi I; Adar R
    J Cardiovasc Surg (Torino); 1991; 32(6):737-40. PubMed ID: 1752890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta-blocking drugs on peripheral blood flow in intermittent claudication.
    Smith RS; Warren DJ
    J Cardiovasc Pharmacol; 1982; 4(1):2-4. PubMed ID: 6176794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.